Literature DB >> 1326128

Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections.

M Yliskoski1, A Tervahauta, S Saarikoski, R Mäntyjärvi, K Syrjänen.   

Abstract

A prospective follow-up of 530 women with cervical human papillomavirus (HPV) infection was conducted from 1981 to the present (mean 62.9 months). The patients were examined by PAP smears and colposcopy with or without biopsies every sixth month. Endocervical swabs were taken for culture of cytomegalovirus (CMV), herpes simplex virus (HSV), and Chlamydia trachomatis at each visit. During the follow-up period, 179 of the 530 patients (33.8%) had cervical infection and 351 (66.2%) had no coexistent cervicitis. On average, the patients with coexistent cervicitis were younger than those without cervicitis (32 +/- 7.2 years and 37.1 +/- 11.4 years, respectively; P less than 0.0001). C. Trachomatis was isolated from 95 of the 530 women (17.9%), and 19 of the patients had chlamydial cervicitis twice. Cytomegalovirus was isolated from 27 (5.1%) women, 2 of whom also had HSV, and 12 patients had a chlamydial infection. Herpes simplex virus was isolated from 11 (2.1%) women, including 2 patients with coexistent CMV infection. A total of 60 (1.3%) women had nonspecific cervicitis. Of the HPV lesions without coexistent cervical infection, 56.7% regressed, 24.5% persisted, 16.5% progressed, and recurrence was found in 2.3%. The corresponding figures for HPV lesions with coexistent cervicitis were as follows: 66.5%, 22.9%, 9.5%, and 1.1%, respectively. Coexistent active cervical infections had no influence on the clinical course of HPV lesions.

Entities:  

Mesh:

Year:  1992        PMID: 1326128     DOI: 10.1097/00007435-199205000-00005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  3 in total

1.  Multiplex PCR testing detection of higher-than-expected rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active australian women.

Authors:  Christopher J McIver; Nikolas Rismanto; Catherine Smith; Zin Wai Naing; Ben Rayner; M Josephine Lusk; Pamela Konecny; Peter A White; William D Rawlinson
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

2.  Immunotherapy of gynaecological high-risk human papilloma virus infection with human leukocyte ultrafiltrate.

Authors:  H Spitzbart; U B Hoyme
Journal:  Infect Dis Obstet Gynecol       Date:  2000

3.  Sexually transmitted and other genital infections in women with cervical human papillomavirus infection.

Authors:  B Sikström; D Hellberg; S Nilsson; I Kallings; P A Mårdh
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.